<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.2minutemedicine.com/feed/</title><link>https://www.2minutemedicine.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Mon, 19 Jan 2026 11:04:15 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Lyme disease is associated with significant health care costs</title><link>https://www.2minutemedicine.com/lyme-disease-is-associated-with-significant-health-care-costs/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2016/04/18132_lores-300x150.jpg</image_url><description>1. Lyme disease (LD) is associated with substantial health care costs, with per-patient direct costs consistently high across several analytic methods...</description><pubDate>Mon, 19 Jan 2026 16:00:47 GMT</pubDate></item><item><title>2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]</title><link>https://www.2minutemedicine.com/2mm-ai-roundup-lilly-and-nvidias-1b-ai-lab-illuminas-billion-cell-atlas-astrazenecas-modella-deal-and-claude-for-healthcare-jan-19th-2026/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2025/05/Untitled-design-300x170.png</image_url><description>NVIDIA and Lilly put $1B behind AI as core drug infrastructure During the JPMorgan Healthcare Conference week in mid January 2026, NVIDIA and Eli Eli ...</description><pubDate>Mon, 19 Jan 2026 13:45:25 GMT</pubDate></item><item><title>2 Minute Medicine Rewind January 19, 2026</title><link>https://www.2minutemedicine.com/2-minute-medicine-rewind-january-19-2026/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2017/05/DVT2_cc_wiki_JamesHeilmanMD_edited-300x150.jpg</image_url><description>Electronic Intervention for Patient-Managed Benzodiazepine Tapering 1. An electronic intervention promoting self-management of benzodiazepine cessatio...</description><pubDate>Mon, 19 Jan 2026 11:00:51 GMT</pubDate></item><item><title>Ethosuximide may not be effective for the treatment of abdominal pain in irritable bowel syndrome</title><link>https://www.2minutemedicine.com/ethosuximide-may-not-be-effective-for-the-treatment-of-abdominal-pain-in-irritable-bowel-syndrome/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>1. Ethosuximide was not superior to placebo for the treatment of abdominal pain in adults with irritable bowel syndrome. Evidence Rating Level: 1 (Exc...</description><pubDate>Sat, 17 Jan 2026 00:00:52 GMT</pubDate></item><item><title>Edaravone dexborneol improves functional independence in patients with acute ischaemic stroke following endovascular thrombectomy</title><link>https://www.2minutemedicine.com/edaravone-dexborneol-improves-functional-independence-in-patients-with-acute-ischaemic-stroke-following-endovascular-thrombectomy/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>1. Compared to placebo, edaravone dexborneol improved functional independence at 90 days in patients with acute ischaemic stroke who underwent endovas...</description><pubDate>Fri, 16 Jan 2026 00:00:40 GMT</pubDate></item></channel></rss>